The predictive value of miRNA expression for HCC recurrence was evaluated in a hybrid data- and hypothesis-driven approach and combined with clinical risk models (Milan, UCSF, Metroticket 2.0 and AFP). The gene discussed is AFP; the disease is hepatocellular carcinoma.